AtriCure to Announce Fourth Quarter and Full Year 2012 Financial Results
WEST CHESTER, Ohio -- February 18, 2013
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems and systems for the exclusion of the left
atrial appendage, will release its financial results for the fourth quarter
and full year 2012 on Thursday, February 28, 2013.
AtriCure will host a conference call at 4:30 p.m. Eastern Time on Thursday,
February 28, 2013 to discuss its fourth quarter and full year 2012 financial
results. A live webcast of the conference call will be available online from
the investor relations page of AtriCure’s corporate website at
Pre-registration is available and recommended for this call at the following
You may also access this call through an operator by calling (888) 713-4217
for domestic callers and (617) 213-4869 for international callers at least 15
minutes prior to the call start time using reservation code 53242423.
The webcast will be available on AtriCure’s website and a telephonic replay of
the call will also be available through April 7, 2013. The replay dial-in
numbers are (888) 286-8010 for domestic callers and (617) 801-6888 for
international callers. The reservation code is 18558054.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company and a leader in developing,
manufacturing and selling innovative cardiac surgical ablation systems
designed to create precise lesions, or scars, in cardiac, or heart, tissue for
the treatment of atrial fibrillation, or AF, and systems for the exclusion of
the left atrial appendage. For more information, please visit
Andy Wade, Vice President and Chief Financial Officer, 513-755-4564
Investor Relations Contact:
Lynn Pieper, 415-202-5678
Press spacebar to pause and continue. Press esc to stop.